HLA antibody monitoring in Chinese population

Application of HLA-specific antibodies in monitoring frequency and rejection after renal transplantation in Chinese population

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500095330

Enrollment

Unknown

Registered

2025-01-06

Start date

2025-03-01

Completion date

Unknown

Last updated

2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage organ failure

Interventions

Research group:Inapplicability

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Be over 18 years old and under 65 years old. 2. Male or female patients who have received this allograft for the first time. 3. Donor high-resolution genotyping. 4. No prior history of neurological and/or psychiatric disorders. 5. Participants (adults) must volunteer and sign a consent form.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the inclusion criteria. 2. Patients infected with hepatitis B or C. 3. Patients who did not follow up on time or irregular follow-up after transplantation. 4. Cases deemed unsuitable by clinicians.

Design outcomes

Primary

Measure	Time frame
Rejection monitoring;	—

Secondary

Measure	Time frame
HLA antibody specific detection;	—

Countries

China

Contacts

Public ContactXue Wujun

The First Affiliated Hospital of Xi'an Jiaotong University

xwujun@126.com+86 29 85323215

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026